
Hong Kong-based biotechnology company CK Life Sciences has added to its wine assets with the acquisition of Australian winery Edinger Estate.
The majority of CK Life Sciences’ vineyards have long-term leases with domestic wine companies.
Hong Kong-based biotechnology company CK Life Sciences has added to its wine assets with the acquisition of Australian winery Edinger Estate.